Selected products targeting proprotein convertase subtilisin/kexin 9 (PCSK9) to treat hypercholesterolemia. Source: BCIQ: BioCentury Online Intelligence

Company

Product

Modality

Delivery

Status

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)/Sanofi (Euronext:SAN; NYSE:SNY)

REGN727 (SAR-236553)

mAb

SC

Ph III (unveiling full
Ph III program in 2Q)